Daiwa Securities Group Inc. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16
-57.9%
4190.0%0.00%
Q2 2023$38
+31.0%
419
-5.8%
0.00%
Q1 2023$29
+26.1%
4450.0%0.00%
Q4 2022$23
-99.9%
445
+12.1%
0.00%
Q3 2022$27,000
+50.0%
3970.0%0.00%
Q2 2022$18,000
+20.0%
397
+33.2%
0.00%
Q1 2022$15,000
+7.1%
2980.0%0.00%
Q4 2021$14,000
+40.0%
2980.0%0.00%
Q3 2021$10,0000.0%298
+87.4%
0.00%
Q2 2021$10,000
+42.9%
1590.0%0.00%
Q1 2021$7,000
-12.5%
159
+12.0%
0.00%
Q4 2020$8,000
-38.5%
142
-66.1%
0.00%
Q3 2020$13,000
+18.2%
4190.0%0.00%
Q2 2020$11,0000.0%4190.0%0.00%
Q1 2020$11,0000.0%419
+16.1%
0.00%
Q4 2019$11,000
+10.0%
361
-9.3%
0.00%
Q3 2019$10,0000.0%3980.0%0.00%
Q2 2019$10,000
+42.9%
398
+11.2%
0.00%
Q1 2019$7,0000.0%358
-28.4%
0.00%
Q4 2018$7,0005000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders